Gevo, Inc. GEVO
Major Chemicals · IPO 2011 · data as of November 13, 2026
Gevo, Inc. (GEVO) is a industrial company listed in the US with a market value of about $453M. In the twelve months to September 30, 2026 it had revenue of $218M and net income of -$182M, a net margin of -83.7%.
Its overall Stock Analiz score is 1.6 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 96% a year, a 5-year average ROIC of -9%.
About Gevo
Gevo is listed in the US and classified in major chemicals, IPO year 2011. Revenue went from $28M in 2014 to $161M in 2025, growth of about 17.1% a year. It was profitable in 0 of the last 10 years in our data. Its share count rose by 6% over three years (dilution for shareholders). It spends 3% of revenue on research and development.
Score: 1.6 / 5
Checks passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $218M | $161M | $17M | $17M | $1M | $711000 | $6M | $24M | $33M | $28M | $27M |
| Net income | -$182M | -$34M | -$79M | -$66M | -$98M | -$59M | -$40M | -$29M | -$28M | -$25M | -$37M |
| Free cash flow | -$31M | -$44M | -$108M | -$108M | -$128M | -$105M | -$26M | -$27M | -$18M | -$23M | -$26M |
| EPS (diluted) | $-0.77 | $-0.14 | $-0.34 | $-0.28 | $-0.44 | $-0.30 | $-0.71 | $-2.35 | $-5.74 | $-30.23 | $-193.52 |
| Net margin | -83.7% | -21.1% | -464.9% | -385.0% | -8341.0% | -8326.7% | -725.9% | -117.0% | -85.1% | -89.5% | -136.8% |
| ROIC | — | -2.5% | -12.9% | -10.3% | -12.0% | -7.7% | -14.4% | -28.4% | -17.3% | -28.9% | -18.1% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 4 analysts is $5.11, 179% above the current price; targets range from $1.20 to $14.00; the consensus rating is “Buy”; expected EPS is $-0.69 for the fiscal year ending December 31, 2026.
Frequently asked questions
Does Gevo pay a dividend?
Not currently.
Is Gevo a good stock to buy?
We do not give buy or sell advice. Gevo scores 1.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.